Pluristem Therapeutics Reports Successful Case Study in Treatment of Buerger’s Disease Patient
Pluristem Therapeutics, Inc. (PSTI)
Last pluristem therapeutics, inc. earnings: 2/6 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
pluristem.com
Company Research
Source: GlobeNewswire
Buerger’s disease is a severe vascular inflammatory disease associated with high risk of amputationPatient was at a pre-amputation stage and was treated with PLX-PAD cell therapy under compassionate use treatmentAfter a 12 month follow up period, PLX-PAD restored peripheral blood supply to the injured limb and prevented amputationPLX-PAD was granted Orphan Drug Designation by the FDA for the treatment of Buerger’s disease and an expanded access program for the treatment of critical limb ischemia HAIFA, Israel, Jan. 09, 2019 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative-medicine company developing novel placenta-based cell therapy products, today reported a successful one-year follow up of a compassionate use treatment in a Buerger’s disease patient treated with Pluristem’s PLX-PAD. The thirty-six years old patient, who was diagnosed with Buerger’s disease approximately four years ago, displayed painful, non-healing ulcers
Show less
Read more
Impact Snapshot
Event Time:
PSTI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PSTI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PSTI alerts
High impacting Pluristem Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics